Understanding SH3BP-1: Potential Drug Targets and Biomarkers (P18895)

Target Name: SH3 domain-binding protein 1

NCBI ID: P18895

SH3 domain-binding protein 1

Other Name(s): SH3 domain binding protein 1 | 3BP-1

Understanding SH3BP-1: Potential Drug Targets and Biomarkers

SH3 Domain-Binding Protein 1 (SH3BP-1) is a protein that is expressed in various tissues and cells in the human body. It is a member of the SH3 family of proteins, which are known for their ability to interact with and modulate the activity of various signaling proteins. One of the most well-known functions of SH3BP-1 is its role in cell signaling, particularly in the regulation of protein kinase (PK) signaling pathways.

In recent years, researchers have become increasingly interested in the potential drug targets and biomarkers for SH3BP-1. This is because the SH3BP-1 protein has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key challenges in studying SH3BP-1 as a drug target is its complex structure and function. SH3BP-1 is a 21 kDa protein that contains a unique SH3 domain, as well as multiple other functional domains, including a catalytic domain, a regulatory domain, and a transmembrane domain. The SH3 domain is the most well-studied of the SH3BP-1 protein, and it is known to play a critical role in its functions, including the regulation of protein kinase signaling pathways.

The SH3 domain is a small protein domain that is characterized by a core of parallel beta-helices and a number of distinct side chains. The SH3 domain is known for its ability to interact with a wide variety of protein substrates, including small molecules, ions, and other proteins. This interaction is known as SH3-mediated interaction, and it is a key mechanism by which SH3BP-1 modulates the activity of various signaling proteins.

One of the most well-studied functions of the SH3 domain is its role in the regulation of protein kinase (PK) signaling pathways. PK signaling pathways are involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and survival. The SH3 domain is known to play a critical role in the regulation of PK signaling pathways, and it is thought to interact with multiple protein substrates that are involved in this process.

In addition to its role in PK signaling pathways, the SH3 domain is also involved in the regulation of several other cellular processes, including the regulation of cell adhesion, the assembly and disassembly of organelles, and the regulation of ion channels. The SH3BP-1 protein is also shown to play a role in the regulation of cellular signaling pathways that are involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Given the complexity and importance of the SH3 domain in SH3BP-1 function, it is no wonder that researchers are interested in identifying potential drug targets for this protein. One approach that is being explored is the use of small molecules to libraries approach to identify compounds that can interact with the SH3 domain and modulate the activity of SH3BP-1. This approach has the advantage of identifying compounds that are not specific for a particular function of the protein, but rather identify compounds that can interact with any of the various functions of the protein.

Another approach that is being explored is the use of SH3BP-1 as a biomarker for disease diagnosis and treatment. The SH3BP-1 protein is expressed in a wide variety of tissues and cells in the human body, and it is thought to be involved in the regulation of many different cellular processes. This makes it an attractive candidate for use as a biomarker for a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, SH3 Domain-Binding Protein 1 (SH3BP-1) is a complex protein that is involved in a wide range of cellular processes in the human body. The SH3 domain is a key component of its function, and it is thought to play a critical role in the regulation of protein kinase (PK) signaling pathways as well as several other cellular processes. As a result, SH3BP-1 is an attractive candidate for use as a drug target or biomarker for a wide range of diseases. Further research is needed to fully understand the complex structure and function of SH3BP-1 and its potential as a drug target or biomarker.

Protein Name: SH3 Domain-binding Protein 1

The "SH3 domain-binding protein 1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SH3 domain-binding protein 1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets